Targeting Nuclear Bile Acid Receptors for Liver Disease

Publisher： Karger

E-ISSN： 1421-9875|29|1|98-102

ISSN： 0257-2753

Source： Digestive Diseases, Vol.29, Iss.1, 2011-06, pp. : 98-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

By Zollner G.   Fickert P.   Fuchsbichler A.   Silbert D.   Wagner M.   Arbeiter S.   Gonzalez F.J.   Marschall H.-U.   Zatloukal K.   Denk H.   Trauner M.  

Journal of Hepatology, Vol. 39, Iss. 4, 2003-10 ,pp. : 480-488

Elsevier

Access to resources Recommend Favorite

Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease

By  

Digestive Diseases, Vol. 34, Iss. 5, 2016-06 ,pp. : 580-588

Karger

Access to resources Recommend Favorite

Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 282-287

Karger

Access to resources Recommend Favorite

The Bile Acid Receptor TGR5 and Liver Regeneration

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Nuclear Receptor Variants in Liver Disease

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 415-419

Karger

Access to resources Recommend Favorite